United States · FDA National Drug Code directory

Fexofenadine HCL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72789-196_40ac042c-0bf7-c7f4-e063-6294a90a4094
Product NDC
72789-196
Form
TABLET
Composition / generic term
Fexofenadine HCL
Labeler
PD-Rx Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20190218
Source listing expiry
20261231

Source-listed ingredients

  • FEXOFENADINE HYDROCHLORIDE — 180 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET in 1 BOTTLE, PLASTIC (72789-196-10) · 72789-196-10
  • 30 TABLET in 1 BOTTLE, PLASTIC (72789-196-30) · 72789-196-30
  • 90 TABLET in 1 BOTTLE, PLASTIC (72789-196-90) · 72789-196-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →